These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 36483433

  • 1. Clinical burden of recurrent Clostridioides difficile infection in the medicare population: A real-world claims analysis.
    Feuerstadt P, Nelson WW, Teigland C, Dahdal DN.
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e60. PubMed ID: 36483433
    [Abstract] [Full Text] [Related]

  • 2. Health care resource utilization and costs of recurrent Clostridioides difficile infection in the elderly: a real-world claims analysis.
    Nelson WW, Scott TA, Boules M, Teigland C, Parente A, Unni S, Feuerstadt P.
    J Manag Care Spec Pharm; 2021 Jul; 27(7):828-838. PubMed ID: 33703939
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mortality, Health Care Use, and Costs of Clostridioides difficile Infections in Older Adults.
    Feuerstadt P, Nelson WW, Drozd EM, Dreyfus J, Dahdal DN, Wong AC, Mohammadi I, Teigland C, Amin A.
    J Am Med Dir Assoc; 2022 Oct; 23(10):1721-1728.e19. PubMed ID: 35288083
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical complications in patients with primary and recurrent Clostridioides difficile infection: A real-world data analysis.
    Feuerstadt P, Boules M, Stong L, Dahdal DN, Sacks NC, Lang K, Nelson WW.
    SAGE Open Med; 2021 Oct; 9():2050312120986733. PubMed ID: 33505698
    [Abstract] [Full Text] [Related]

  • 8. Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study.
    Ghosh S, Antunes A, Rinta-Kokko H, Chaparova E, Lay-Flurrie S, Tricotel A, Andersson FL.
    Int J Infect Dis; 2024 Mar; 140():31-38. PubMed ID: 38185320
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Economic Impact of Recurrent Clostridioides difficile Infection in the USA: A Systematic Literature Review and Cost Synthesis.
    Reveles KR, Yang M, Garcia-Horton V, Edwards ML, Guo A, Lodise T, Bochan M, Tillotson G, Dubberke ER.
    Adv Ther; 2023 Jul; 40(7):3104-3134. PubMed ID: 37210680
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
    Zhang D, Prabhu VS, Marcella SW.
    Clin Infect Dis; 2018 Apr 17; 66(9):1326-1332. PubMed ID: 29360950
    [Abstract] [Full Text] [Related]

  • 18. Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.
    Mikamo H, Kondo T, Okuyama K, Marcella SW, Ruzicka DJ.
    Anaerobe; 2020 Feb 17; 61():102139. PubMed ID: 31830597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.